SBIR/STTR Research Award
SBIR Topic 109: Development of Monoclonal Antibody- Mediated Interventions to Combat Malaria
Award amount
$1,500,000Program and phase
SBIR · Phase IIAward year
2024Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CURE SYSTEMS LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- CV8RCUBHN248
- Solicitation number
- PHS-2022-1
- Topic code
- 109
Research abstract
To support the development of monoclonal antibody- mediated interventions to combat Malaria.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- VECTOR-BASED DELIVERY OF HIV BROADLY NEUTRALIZING ANTIBODIES
- Development of monoclonal antibody-mediated interventions to combat malaria
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Development of monoclonal antibody-mediated interventions to combat malaria
- Development of afucosylated monoclonal antibodies with enhanced effector functions to combat malaria
- Multi-path DCS as a novel non-invasive treatment for amyotrophic lateral sclerosis
- SBIR TOPIC 109, PHASE I - TRANSCATHETER TRILEAFLET TRICUSPID SUTURE REPAIR SYSTEM
Research funding history
3 SBIR/STTR records share this UEI (2022–2024). Reported award amounts total $2,099,777. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services